A new scientific breakthrough in curing disease is dominating talk among top institutional investors and the leading pharmaceutical companies.
A new scientific breakthrough in curing disease is dominating talk among top institutional investors and the leading pharmaceutical companies. The largest drug companies have invested billions of dollars into this treatment. Juno Pharma just invested $700 million. Baxter Labs invested $62.5 million. Glaxo SmithKline invested $350 million. Johnson and Johnson invested $292 million. Allergan invested $90 million. Novartis invested $83.5 million. And that’s on top of the $120 million Bill Gates and Google Ventures already invested into this. The list goes on and on… Never before has medical science moved into a new technology so quickly. The Nobel Laureate committee called it the “Holy Grail” of medicine. Here’s the Insider Scoop – Window for Opportunity is OPEN |
|
| | Sometimes, colleagues of InvestmentBankingRules share special offers with us that we think our readers should be made aware of. Above is one such special opportunity that we believe deserves your attention. |
|
|
From time to time, we send special emails or offers to readers who chose to opt-in. We hope you find them useful. This email sent to you newsletter@newslettercollector.com by InvestmentBankingRules.com on behalf of Event Horizon LLC. Privacy Policy | Terms & Conditions | Update Profile Unsubscribe 2024 All Rights Reserved.435 N Dupont Hwy, Dover, DE 19901, United States |
|
|
|